Inhibition of ANO1 by Cis- and Trans-Resveratrol and Their Anticancer Activity in Human Prostate Cancer PC-3 Cells
International Journal of Molecular Sciences · 07.01.2023 · 24 (2) · 1186
DOI: 10.3390/ijms24021186 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.01.2023. Verfasst von Dongkyu Jeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Yonsei, Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Ko…. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Prostatic Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Anoctamin1 (ANO1), a calcium-activated chloride channel, is involved in the proliferation, migration, and invasion of various cancer cells including head and neck squamous cell carcinoma, lung cancer, and prostate cancer. Inhibition of ANO1 activity or downregulation of ANO1 expression in these cancer cells is known to exhibit anticancer effects. Resveratrol, a natural polyphenol abundant in wines, grapes, berries, soybeans, and peanuts, shows a wide variety of biological effects including anti-inflammatory, antioxidant, and anticancer activities. In this study, we investigated the effects of two stereoisomers of resveratrol on ANO1 activity and found that cis- and trans-resveratrol inhibited ANO1 activity with different potencies. Cis- and trans-resveratrol inhibited ANO1 channel activity with IC50 values of 10.6 and 102 μM, respectively, and had no significant effect on intracellular calcium signaling at 10 and 100 μM, respectively. In addition, cis-resveratrol downregulated mRNA and protein expression levels of ANO1 more potently than trans-resveratrol in PC-3 prostate cancer cells. Cis- and trans-resveratrol significantly reduced cell proliferation and cell migration in an ANO1-dependent manner, and both resveratrol isomers strongly increased caspase-3 activity, PARP cleavage, and apoptotic sub-G1 phase ratio in PC-3 cells. These results revealed that cis-resveratrol is a potent inhibitor of ANO1 and exhibits ANO1-dependent anticancer activity against human metastatic prostate cancer PC-3 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Yonsei, Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea.
- Department of Physiology, College of Medicine, Dongguk University, 123 Dongdae-ro, Gyeongju 38066, Republic of Korea.
- Channelopathy Research Center (CRC), College of Medicine, Dongguk University, 32 Dongguk-ro, Ilsan Dong-gu, Goyang 10326, Republic of Korea.
ORCID-Profile: Dongkyu Jeon, Minjae Jo, Yechan Lee, So-Hyeon Park, Hong Thi Lam Phan, Joo Hyun Nam, Wan Namkung
Förderung
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Jeon, D., Jo, M., Lee, Y., Park, S. H., Phan, H. T. L., Nam, J. H., & Namkung, W. (2023). Inhibition of ANO1 by Cis- and Trans-Resveratrol and Their Anticancer Activity in Human Prostate Cancer PC-3 Cells. International Journal of Molecular Sciences, 24(2), 1186. https://doi.org/10.3390/ijms24021186
Vancouver
Jeon D, Jo M, Lee Y, Park SH, Phan HTL, Nam JH, et al. Inhibition of ANO1 by Cis- and Trans-Resveratrol and Their Anticancer Activity in Human Prostate Cancer PC-3 Cells. International Journal of Molecular Sciences. 2023;24(2):1186. doi:10.3390/ijms24021186
BibTeX
@article{Jeon2023,
author = {Jeon, Dongkyu and Jo, Minjae and Lee, Yechan and Park, So-Hyeon and Phan, Hong Thi Lam and Nam, Joo Hyun and Namkung, Wan},
title = {Inhibition of ANO1 by Cis- and Trans-Resveratrol and Their Anticancer Activity in Human Prostate Cancer PC-3 Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1186},
doi = {10.3390/ijms24021186}
}
EUVIMED